Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer

OBJECTIVE: The need to perform genetic sequencing to diagnose the polymerase epsilon exonuclease (POLE) subtype of endometrial cancer (EC) hinders the adoption of molecular classification. We investigated clinicopathologic and protein markers that distinguish the POLE from the copy number (CN)-low s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kidong, Hwangbo, Suhyun, Kim, Hyojin, Kim, Yong Beom, No, Jae Hong, Suh, Dong Hoon, Park, Taesung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024182/
https://www.ncbi.nlm.nih.gov/pubmed/35128857
http://dx.doi.org/10.3802/jgo.2022.33.e27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024182/
https://www.ncbi.nlm.nih.gov/pubmed/35128857
http://dx.doi.org/10.3802/jgo.2022.33.e27

Ejemplares similares